Related Experiment Video
Updated: Apr 28, 2026

Frailty Assessment in an Aging Mouse Model
Published on: September 23, 2025
Risk prediction models for frailty in stroke patients: a systematic review and meta-analysis
Lingling Guo1,2, Yi He1,2, Wen Tang1,2
1Department of Rehabilitation Medicine, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Objective:
To systematically review the frailty risk prediction models for stroke patients.
Data Sources:
Eight databases including PubMed, Web of Science, the Cochrane Library, Embase, CINAHL, CNKI, Wanfang Database, VIP and SinoMed were systematically searched from the inception of the databases to May 31, 2025.
Study Selection:
Studies were screened independently by two researchers with systematic evidence-based training. In this review, We extracted data based on Data Extraction for Systematic Reviews of Prediction Modeling Studies (CHARMS).
Data Extraction:
Two researchers independently screened the literature and extracted study data. We employed the Prediction Model Risk of Bias Assessment Tool (PROBAST) to assess both the risk of bias and applicability of the included studies.
Data Synthesis:
A total of 19 studies and 24 frailty risk prediction models for stroke patients were included. The area under the Receiver operating Characteristic curve (AUC) of the included models ranged from 0.629 to 0.940, with 21 models having an AUC > 0.7. The combined AUC value of the 10 validation models was 0.87. However, all studies were at high risk of bias according to PROBAST, suggesting this estimate is likely inflated due to methodological weaknesses. The most frequently used predictors in the included models were age, activities of daily living, and NIHSS score.
Conclusion:
Current frailty prediction models for stroke patients have methodological weaknesses and high risk of bias. All included studies were from China (2023-2025), severely limiting generalizability to other populations. The pooled AUC (0.87) is likely inflated and should be interpreted cautiously. Rigorous external validation in diverse settings is needed before clinical use. Future studies should expand the sample size, strictly carry out study design and carry out multi-center external validation.
Systematic Review Registration:
https://www.crd.york.ac.uk/PROSPERO/view/CRD420251075547.
More Related Videos
04:00Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles
Published on: July 26, 2024
05:53Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013